{"article_link": "https://doi.org/10.1016/j.celrep.2023.113568", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://github.com/petebio/Gene_regulatory_network_analysis", "format": "txt/csv", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE236775"}, {"id": "data_2", "omics": "Epigenomics", "link": "https://github.com/petebio/Gene_regulatory_network_analysis", "format": "txt/csv", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE108316"}], "analyses": [{"id": "analysis_1", "analysis_type": "Gene Regulatory Network Construction", "analysis_data": ["data_1", "data_2"], "label": {"group": ["FLT3-ITD+ AML", "healthy PBSCs"]}}, {"id": "analysis_2", "analysis_type": "shRNA Drop-out Screen", "analysis_data": ["data_1"], "training_set": ["MOLM14", "MV4-11"], "test_set": ["MOLM14 in NSG mice"], "label": {"cell_line": ["MOLM14", "MV4-11"], "mouse_model": ["NSG"]}}, {"id": "analysis_3", "analysis_type": "Functional Viability and Colony Formation Analysis", "analysis_data": ["data_1"], "label": {"treatment": ["CBFβi", "DMSO"], "cell_type": ["AML", "healthy PBSCs", "RUNX1 (2x)"]}}, {"id": "analysis_4", "analysis_type": "Differential Gene Expression Analysis", "analysis_data": ["data_1", "data_2"], "label": {"mutation_status": ["FLT3-ITD/NPM1", "wild-type"], "cell_type": ["AML", "PBSC"]}}, {"id": "analysis_5", "analysis_type": "Regulatory Module Enrichment Analysis", "analysis_data": ["data_1", "data_2"], "label": {"condition": ["treated", "untreated"], "mutation_status": ["FLT3-ITD/NPM1", "wild-type"], "cell_type": ["AML", "PBSC"]}}], "results": [{"analysis_id": "analysis_1", "metric": "Shared Edge Frequency", "value": "50%", "features": ["RUNX1", "ETS", "AP-1", "C/EBP", "NFiX", "FOX", "EGR"], "description": "Over 50% of regulatory interactions are shared across FLT3-ITD+ AML patients, indicating a conserved gene regulatory network."}, {"analysis_id": "analysis_2", "metric": "Hit Rate", "value": "nearly 50%", "features": ["RUNX1", "NFIL3", "EGR1", "FOS", "CEBPA", "KLF2", "IRX3", "MYB", "DUSP6", "IL8", "NFATC1", "FOXC1"], "description": "Nearly 50% of screened genes are essential for FLT3-ITD+ AML cell growth in vitro and in vivo."}, {"analysis_id": "analysis_3", "metric": "Viability Reduction", "value": "efficiently killed most cells", "features": ["RUNX1", "NFiX", "EGR1", "AP-1", "CEBP"], "description": "CBFβi treatment efficiently kills most FLT3-ITD+ AML cells but spares healthy PBSCs."}, {"analysis_id": "analysis_3", "metric": "Cell Cycle Block", "value": "G1 arrest", "features": ["RUNX1", "NFiX", "EGR1", "AP-1", "CEBP"], "description": "CBFβi induces G1 cell cycle arrest in FLT3-ITD+ AML cells."}, {"analysis_id": "analysis_4", "metric": "Fold Change Threshold", "value": ">2", "features": ["CSF1R", "IRF8", "DUSP5", "DUSP6", "PLB1", "MATK", "KLF2", "KLF6"], "description": "Genes with a fold change >2 in RNA-seq are critical for FLT3-ITD+ AML regulation."}, {"analysis_id": "analysis_5", "metric": "Fold Change Threshold", "value": ">2", "features": ["RUNX1", "NFiX", "EGR1", "AP-1", "CEBP", "DUSP5", "DUSP6"], "description": "Genes with a fold change >2 in RNA-seq and chromatin accessibility data are identified as significantly regulated."}]}